FindTrial
Sign In

Minimum Effective Anesthetic Volume of Ropivacaine 0.5% for Sciatic Nerve Block in Arthroscopic Surgeries of Knee

Minimum Effective Anesthetic Volume of Ropivacaine 0.5% for Sciatic Nerve Block in Arthroscopic Surgeries of Knee

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-16008025
Enrollment
Unknown
Registered
2016-02-29
Start date
2015-11-06
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Surgery

Interventions

ultrasound with nerve stimulation group:sciatic nerve block at subgluteal injection under guidance of ultrasound with nerve stimulation

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients of American Society of Anesthesiologists physical status I-II, aged 18-50 years old, scheduled for arthroscopic meniscus or cruciate ligaments repair of knee were included.

Exclusion criteria

Exclusion criteria: Exclusion criteria consisted of patient refusal, pregnancy, history of diabetes mellitus, neuropathic or neuromuscular disease, coagulopathy, or skin infection at the site of needle insertion.

Design outcomes

Primary

MeasureTime frame
Effective volume of ropivacaine 0.5% for sciatic nerve block;—

Countries

China

Contacts

Public ContactZhiheng Liu
15818585570@163.com+86 15818585570

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026